Retraction
Smad4 gene silencing enhances the chemosensitivity of human lymphoma cells to adriamycin via inhibition of the activation of transforming growth factor β signaling pathway
Paper Information
Record ID:
40719
Author(s):
Journal:
Publication Date:
May 26, 2019
Retraction Date:
November 17, 2022
(3.0 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (4)
4
Total Citations0
Post-Retraction3
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Downregulation of Smad4 expression confers chemoresistance against imatinib mesylate to chronic myeloid leukemia K562 cells
Jiangzhao Zhang, Min Zhang, Yan Liang et al. (5 authors)
Hematology
Open Access
Published: Dec 2021
3 citations
3 citations
325 days before retraction
Inhibitory effect of dihydromyricetin on the proliferation of JAR cells and its mechanism of action
Yanzhen Zuo, Yanjie Lu, Qian Xu et al. (7 authors)
Oncology Letters
Open Access
Published: Apr 2020
20 citations
20 citations
945 days before retraction
Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma
Liling Jiang, Yuening Sun, Jinxiang Wang et al. (10 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Nov 2019
36 citations
36 citations
1107 days before retraction
Quick Stats
Total Citations:
6
Years Since Retraction:
3.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025